{"schema_version":"secwatch.filing_event.v1","accession":"0001654954-25-005812","form_type":"8-K","ticker":"PBSV","cik":"0001304161","company_name":"Pharma-Bio Serv, Inc.","filed_at":"2025-05-16T23:59:59+00:00","discovered_at":"2026-05-14T18:02:47.870687+00:00","generated_at":"2026-05-21T02:54:19.437055+00:00","sec_items":["5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Pharma-Bio Serv annual meeting elects Howard Spindel, approves say on pay every three years","bullets":["Howard Spindel elected Class III director with 7,265,978 votes for, 2,359,070 withheld; 3,264,532 broker non-votes.","Ratification of Crowe PR PSC as auditor for FY25 passed with 12,887,897 votes for, 1,701 against.","Non-binding advisory vote on executive compensation approved: 8,979,762 for, 65,851 against, 579,435 abstain.","Advisory vote on frequency: plurality favored 3 years (6,645,421 votes); company will hold say on pay every three years."],"urls":{"canonical":"https://secwatch.observer/filing/0001654954-25-005812","json":"https://secwatch.observer/filing/0001654954-25-005812.json","markdown":"https://secwatch.observer/filing/0001654954-25-005812.md","text":"https://secwatch.observer/filing/0001654954-25-005812.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1304161/000165495425005812/0001654954-25-005812-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1304161/000165495425005812/pbsv_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-21T02:54:19.437055+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}